Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation

Genes and Development

Volumn 16, Issue 14, 2002, Pages 1792-1805

  Lazaro, Jean Bernard ^a   Bailey, Peter J ^a,b   Lassar, Andrew B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cyclin D; Differentiation; GRIP 11; MEF2; Myogenesis

Indexed keywords

CYCLIN D; GENE PRODUCT; MYOCYTE ENHANCER FACTOR 2; PROTEIN GRIP 1; PROTEIN KINASE P60; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE DISRUPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

3T3 CELLS; ANIMALS; BIOLOGICAL TRANSPORT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; CYTOPLASM; DNA-BINDING PROTEINS; HELIX-LOOP-HELIX MOTIFS; HISTONE DEACETYLASES; MICE; MUSCLE, SKELETAL; MYOGENIC REGULATORY FACTORS; NUCLEAR RECEPTOR COACTIVATOR 2; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA;

EID: 0037099488     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.U-9988R     Document Type: Article

References (57)

1. The protein Id: A negative regulator of helixloop-helix DNA binding proteins
2. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins
3. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection
4. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage
5. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation
6. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation
7. Subcellular localization of the steroid receptor coactivators (SRCs) and MEF2 in muscle and rhabdomyosarcoma cells
8. Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products
9. Expression of a single transfected cDNA converts fibroblasts to myoblasts
10. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation
11. INK4C and its predominant association with CDK4 and CDK6 during myogenic differentiation
12. CBP/p300 in cell growth, transformation, and development
13. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
14. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
15. The p21 cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases
16. Function of a human cyclin gene as an oncogene
17. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7
18. Regulation of exit from quiescence by p27 and cyclin D1-CDK4
19. Functional activity of myogenic HLH proteins requires heterooligomerization with E12/E47-like proteins in vivo
20. mHDAI/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity
21. The SRC family of nuclear receptor coactivators
22. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains
23. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases
24. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases
25. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins
26. Histone acetyltransferases: Function, structure, and catalysis
27. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5
28. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
29. Control of muscle development by dueling HATs and HDACs
30. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases
31. HDAC4 deacetylase associates with and represses the MEF2 transcription factor
32. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins
33. Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis
34. MEF2: A transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation
35. Cyclin DI stimulation of estrogen receptor transcriptional activity independent of cdk4
36. 2 phases of the cell cycle
37. Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation
38. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor β. A role for cyclin DI in control of myoblast differentiation
39. Ectopic expression of cyclin DI prevents activation of gene transcription by myogenic basic helix-loop-helix regulators
40. Molecular mechanisms of myogenic coactivation by p300: Direct interaction with the activation domain of MyoD and with the MADS box of MEF2C
41. Temporally distinct and ligand-specific recruitment of nuclear receptor interacting peptides and cofactors to subnuclear domains containing the estrogen receptor
42. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase
43. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRb hyperphosphorylation
44. MEF-2 function is modified by a novel corepressor, MITR
45. Subnuclear trafficking of estrogen receptor-α and steroid receptor coactivator-1
46. Subnuclear dynamics and transcription factor function
47. MyoDl: A nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts
48. Distinct roles for cyclin-dependent kinases in cell cycle control
49. The Mef2e gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development
50. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex
51. Regulation of MyoD function in the dividing myoblast
52. The MyoD family and myogenesis: Redundancy, networks, and thresholds
53. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps
54. p38 mitogen activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2e transcription factor
55. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4
56. p21(CIPI) and p57(KIP2) control muscle differentiation at the myogenin step
57. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1